Tumor markers in biological fluids associated with pregnancy (Q34609148)

3 August 2017

1 reference

title

Tumor markers in biological fluids associated with pregnancy (English)

1 reference

3 August 2017

3

Demetrios Rizos

1 reference

3 August 2017

Angeliki Sarandakou

1

1 reference

3 August 2017

Efthimia Protonotariou

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2007

1 reference

Critical Reviews in Clinical Laboratory Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

44

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

151-178

1 reference

Tumor markers in gynecologic cancer

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Predictive value of serial carcinoembryonic antigen levels in long-term follow-up of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumour-associated antigens, CEA, CA 125 and SCC in serum and follicular fluid of stimulated and unstimulated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

The tumor marker CA 125 is a common constituent of normal cervical mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Maternal immune responses to oncofetal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Second trimester serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Serum-alpha1-fetoprotein in patients with testicular tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Human Chorionic Gonadotropin — A Hormone Secreted for Many Reasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Specific carcinoembryonic antigens of the human digestive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Cea and nca in amniotic fluid of normal and abnormal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumour marker antigens during menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Reactivity of a monoclonal antibody with human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumour markers in oncology: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumor markers in non-malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Amniotic Fluid and Maternal Serum Levels of CA125 in Pregnancies affected by Down Syndrome: a Re-evaluation of the Role of CA125 in Down Syndrome Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

21 January 2018

Mucin-Type Glycoproteins

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Recent insights into the assembly, dynamics, and function of intermediate filament networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Clinical utility of cytokeratins as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Human prostate-specific antigen: structural and functional similarity with serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

Kallikreins and kinins in inflammatory-like events in the reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360601003143

10.1080/10408360601003143

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference